Daidzein ameliorates LPS-induced hepatocyte injury by inhibiting inflammation and oxidative stress

This publication has 28 references indexed in Scilit:

• Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary
  Reproductive Biology and Endocrinology, 2019
• Zearalenone induced oxidative stress in the jejunum in postweaning gilts through modulation of the Keap1–Nrf2 signaling pathway and relevant genes1
  Journal of Animal Science, 2019
• Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice
  International Immunopharmacology, 2019
• Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
  Nature Reviews Drug Discovery, 2019
• Apigetrin treatment attenuates LPS-induced acute otitis media though suppressing inflammation and oxidative stress
  Biomedicine & Pharmacotherapy, 2019
• Daidzein, its effects on impaired glucose and lipid metabolism and vascular inflammation associated with type 2 diabetes
  BioFactors, 2018
• The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases
  Biophysical Reviews, 2016
• Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway
  International Immunopharmacology, 2015
• Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease
  World Journal of Gastroenterology, 2014
• Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex
  Proceedings of the National Academy of Sciences, 2013